SHSE:605016 (China)
Â
Class A
Â¥
21.5
-2.19 (-9.24%)
Jul 17
Business Description
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
ISIN : CNE1000052N4
Share Class Description:
SHSE:605016: Class ATotal Employee Number:
990Compare
Compare
Traded in other countries / regions
605016.China Index Membership
SSE Composite Index IPO Date
2021-04-21Description
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.51 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | 0.96 | |||||
Interest Coverage | 72.43 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.12 | |||||
Beneish M-Score | -2.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24 | |||||
3-Year EBITDA Growth Rate | 34.4 | |||||
3-Year EPS without NRI Growth Rate | 37.6 | |||||
3-Year FCF Growth Rate | -83.8 | |||||
3-Year Book Growth Rate | 13.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 29.27 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.89 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.63 | |||||
9-Day RSI | 26.53 | |||||
14-Day RSI | 31.2 | |||||
3-1 Month Momentum % | -3.99 | |||||
6-1 Month Momentum % | 21.35 | |||||
12-1 Month Momentum % | 13.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.51 | |||||
Quick Ratio | 1.97 | |||||
Cash Ratio | 1.25 | |||||
Days Inventory | 113.06 | |||||
Days Sales Outstanding | 71.25 | |||||
Days Payable | 77.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.23 | |||||
Dividend Payout Ratio | 0.21 | |||||
3-Year Dividend Growth Rate | 79.4 | |||||
Forward Dividend Yield % | 1.73 | |||||
5-Year Yield-on-Cost % | 1.12 | |||||
Shareholder Yield % | -1.63 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.09 | |||||
Operating Margin % | 33.84 | |||||
Net Margin % | 27.96 | |||||
EBITDA Margin % | 33.29 | |||||
FCF Margin % | -10.41 | |||||
OCF Margin % | 14.16 | |||||
ROE % | 21.49 | |||||
ROA % | 16.56 | |||||
ROIC % | 25.82 | |||||
3-Year ROIIC % | 28.18 | |||||
ROC (Joel Greenblatt) % | 33.51 | |||||
ROCE % | 24.24 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.94 | |||||
Forward PE Ratio | 18.57 | |||||
PE Ratio without NRI | 21.52 | |||||
Shiller PE Ratio | 53.75 | |||||
Price-to-Owner-Earnings | 47.37 | |||||
PEG Ratio | 1.16 | |||||
PS Ratio | 6.39 | |||||
PB Ratio | 4.33 | |||||
Price-to-Tangible-Book | 4.37 | |||||
Price-to-Operating-Cash-Flow | 48.75 | |||||
EV-to-EBIT | 18.12 | |||||
EV-to-EBITDA | 18.12 | |||||
EV-to-Revenue | 6.03 | |||||
EV-to-FCF | -57.97 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 7.41 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.86 | |||||
Price-to-Graham-Number | 2.04 | |||||
| Price-to-Net-Current-Asset-Value | 13.19 | |||||
Earnings Yield (Greenblatt) % | 5.52 | |||||
FCF Yield % | -1.68 | |||||
Forward Rate of Return (Yacktman) % | 19.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,458.366 | ||
| EPS (TTM) (Â¥) | 0.98 | ||
| Beta | 0.972 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 1.06 | ||
| Volatility % | 23.6 | ||
| 14-Day RSI | 31.2 | ||
| 14-Day ATR (Â¥) | 1.101364 | ||
| 20-Day SMA (Â¥) | 24.3815 | ||
| 12-1 Month Momentum % | 13.08 | ||
| 52-Week Range (Â¥) | 18.75 - 29.1 | ||
| Shares Outstanding (Mil) | 420.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.165000 Cash Dividend | 2026-06-02 | 25.57 (+2.65%) | ||
| CNY 0.050000 Cash Dividend | 2025-12-12 | 19.87 (-2.12%) | ||
| CNY 0.050000 Cash Dividend | 2025-09-12 | 21.09 (-1.54%) | ||
| CNY 0.107692 Cash Dividend | 2025-06-11 | 20.38 (-2.21%) | ||
| 1.3:1 Stock Split | 2025-06-11 | 20.38 (-2.21%) | ||
| CNY 0.015385 Cash Dividend | 2024-12-27 | 13.28 (+0.06%) | ||
| CNY 0.023077 Cash Dividend | 2024-09-13 | 13.29 (-3.46%) | ||
| 1.3:1 Stock Split | 2024-06-06 | 17.65 (-0.53%) | ||
| 1.4:1 Stock Split | 2023-06-01 | 12.54 (+2.17%) | ||
| 1.4:1 Stock Split | 2022-07-01 | 12.69 (+9.88%) |
Show
Entries
Shandong Bailong Chuangyuan Bio-Tech Co Ltd Frequently Asked Questions
What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016)'s stock price today?
The current price of SHSE:605016 is ¥21.50. The 52 week high of SHSE:605016 is ¥29.10 and 52 week low is ¥18.75.
When is next earnings date of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016)?
The next earnings date of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) is .
Does Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) is 1.23% (As of Today), Highest Dividend Payout Ratio of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) was 0.4. The lowest was 0.11. And the median was 0.24. The  Forward Dividend Yield % of Shandong Bailong Chuangyuan Bio-Tech Co Ltd(SHSE:605016) is 1.73%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shandong Bailong Chuangyuan Bio-Tech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers